3Cohn JN. The management of chronic heart failure[J].{H}New England Journal of Medicine,2006,(02):345-498.
4Zhang YH,Lin JX,Vilcek J. Synthesis of interleukin-6(interfevron-β2/B cell stimulatory factor2) in human fibroblasts is triggered by an in crease intracellular cyclic AMP[J].{H}Journal of Biological Chemistry,2008,(30):6177-6178.
5杨在春.新编临床医学数据手册[M]{H}北京:金盾出版社,200210-20.
6Kunisada K,Hirota H,Fujio Y. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes[J].{H}CIRCULATION,1996,(10):2626-2632.
10Magowan GA,Mann DL,Kormos RL. Circulating interleukin-6 in severe heart failure[J].{H}American Journal of Cardiology,2007,(08):1127-1128.
二级参考文献8
1Cohn JN. The managment of chronic heart failure. N Engl Med, 1996,335:490-498.
2Finkel MS,Oddis CV,Jacob TD,et al, Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 1992,257 : 387-389.
3Kunisada K,Hirota H,Fujio Y,et at. Activation of JAKSTAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation, 1996,94:2626-2632.
4Land LG,Schrelner GF, Immune mechanisms of cardiac disease. N Engl J Med,1994,330:1129-1135.
5Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines, Chest, 1994,105 : 897-904.
6Antonipillai YW, Wang Y, Horton R, Tumour necrosis factor and interleukin-1 may regulate renin secretion.Endocrinology, 1990,126 : 273-278.
